Skip to main content
. 2021 May 8;21:248. doi: 10.1186/s12903-021-01597-x

Table 1.

Demographics and clinical characteristics of RA and control subjects

Characteristic Biologic-naïve RA (n = 8) Non-RA control (n = 10) P-value*
Age, years, mean 55.1 (16.5) 53.2 (16.0) 0.81
Female, % 62.5% 70.0% 1.0
Race+, %

 Caucasian

 Non-Caucasian

  African American

  Hispanic

  Indian

  Unknown

50%

50%

25%

12.5%

12.5%

0%

30%

70%

10%

10%

0%

50%

0.63
BMI (kg/m2) 32.6
Diabetes mellitus 0%
Smoking history
 Current 12.5%
 Former 37.5%
 Never 50%
RA disease characteristics
 Remission, % 75%
 Autoantibody status
  RF positive, % 75%
  ACPA positive, % 75%
 ESR mm/h, mean 23.38 (17.73)
 CRP mg/L, mean 4.26 (1.64)
 RAPID3 score, mean 10.42 (5.71)
 Medication history
  DMARDs, % 100%
  Glucocorticoids, % 0%
  Biologic agents
   TNF-inhibitor, % 0%
   Other, % 0%
Number of caries, mean 3 (3.85) 4.4 (7.07) 0.62
Probing depth, mean (mm)
 Shallow sites (PD ≤ 3 mm) 2.58 2.08 0.02
 Deep sites (PD ≥ 4 mm) $ 4.00 3.65 0.47
Global PD status
 Healthy, % 12.5% 0% 0.54
 Periodontitis stage I, % 37.5% 40%
 Periodontitis stage II, % 12.5% 40%
 Periodontitis stage III, % 37.5% 20%

RF, rheumatoid factor; ACPA, anti-cyclic citrullinated protein antibody; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; RAPID3, routine assessment of patient index data 3; DMARD, disease modifying antirheumatic drug; TNF, tumor necrosis factor; PD, periodontal disease. Periodontitis stages are described elsewhere [8, 28]

*Age and pocket depth were compared using Student’s t-test. All other parameters were compared using Fisher’s Exact test. P-value in race was calculated with Caucasian vs. non-Caucasian data. Standard deviation is shown in parentheses

+Race was self-reported

$Probing depths were averaged measurements from the facial and/or lingual sites from which subgingival samples were collected